We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
DORZOTRUS, DORZOSOPT, TRUSOLAMIDE, DORZOLAMIDE NHPL, TRUSOPTIDE, TORZOLAMIDE, DORZOLAMIDE NEOHEALTH (Neo Health (Australia) Pty Ltd)
Product name
DORZOTRUS, DORZOSOPT, TRUSOLAMIDE, DORZOLAMIDE NHPL, TRUSOPTIDE, TORZOLAMIDE, DORZOLAMIDE NEOHEALTH
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
131 working days (255)
Active ingredients
Dorzolamide hydrochloride
Registration type
New generic medicine
Indication
DORZOTRUS, DORZOSOPT, TRUSOLAMIDE, DORZOLAMIDE NHPL, TRUSOPTIDE, TORZOLAMIDE, DORZOLAMIDE NEOHEALTH (eye drops) is indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma